Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
Patents for C07C 401 - Irradiation products of cholesterol or its derivatives; Vitamin d derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation (3,426)
04/2013
04/25/2013WO2013059021A1 2-methylene-vitamin d analogs and their uses
04/25/2013US20130102574 2-methylene-vitamin d analogs and their uses
04/25/2013US20130102573 2-methylene-vitamin d analogs and their uses
04/25/2013US20130102567 3-Desoxy-2-Methylene-Vitamin D Analogs and Their Uses
04/25/2013CA2851283A1 2-methylene-vitamin d analogs and their uses
04/25/2013CA2851275A1 2-methylene-vitamin d analogs and their uses
04/23/2013CA2588396C 17,20(e)-dehydro vitamin d analogs and their uses
04/23/2013CA2535185C 2-methylene-19-nor-vitamin d2 compounds
04/17/2013CN103044301A Photochemical synthesis method of 25-hydroxy vitamin D3
04/16/2013US8420839 Crystallization of 1α-hydroxy-2-methylene-18,19-dinor-homopregnacalciferol
04/11/2013US20130090486 Crystallization of 1alpha-Hydroxy-2-Methylene-18,19-Dinor-Homopregnacalciferol
04/02/2013US8410080 2-methylene-vitamin D analogs and their uses
04/02/2013CA2588410C 2-methylene-19-nor-1.alpha.-hydroxy-17-ene-homopregnacalciferol and its uses
03/2013
03/26/2013US8404874 (20R,25S)-2-Methylene-19,26-Dinor-1α,25-Dihydroxyvitamin D3 in crystalline form
03/26/2013US8404666 2-substituted-1α,25-dihydroxy-19,26,27-trinor vitamin D analogs and uses thereof
03/19/2013US8399439 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
03/19/2013US8399438 2α-methyl-19-nor-1α-hydroxy-homopregnacalciferol and its uses
03/07/2013WO2013032846A1 2-METHYLENE-19,23,24-TRINOR-1α-HYDROXYVITAMIN D3
03/07/2013WO2013032740A1 Crystallization of 1 alpha-hydroxy-20-methylene-19,24,25,26,27-pentanorvitamin d3
03/07/2013CA2846360A1 Crystallization of 1.alpha.-hydroxy-20-methyl-2-methylene-19,24,25,26,27-pentanorvitamin d3
02/2013
02/28/2013US20130053587 Crystallization of 1alpha-Hydroxy-20-Methyl-2-Methylene-19,24,25,26,27-Pentanorvitamin D3
02/28/2013US20130053356 2-methylene-19,23,24-trinor-1alpha-hydroxyvitamin d3
02/27/2013CN102942431A Method for separating chiral compound by using molecular sieves
02/21/2013WO2013023327A1 Side chain of 25-hydroxyvitamin d2 series drug and preparation method thereof
02/21/2013WO2012166938A3 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
02/19/2013US8377913 Vitamin D receptor activators and methods of making
02/14/2013US20130039952 Calcipotriol monohydrate nanocrystals
02/13/2013EP2556055A2 Ship inhibitors and uses thereof
02/13/2013EP2556054A1 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
02/13/2013EP2556053A2 (20s)-2-methylene-19-nor-22-dimethyl-1alpha,25- dihydroxyvitamin d3 and (20r)-2-methylene-19-nor-22-dimethyl-1alpha,25-hydroxyvitamin d3
02/12/2013CA2588401C 17,20(z)-dehydro vitamin d analogs and their uses
02/05/2013CA2620354C Des-c,d analogs of 1.alpha.,25-dihydroxy-19-norvitamin d3
01/2013
01/29/2013US8362287 Stereoselective synthesis of vitamin D analogues
01/24/2013WO2013012644A1 2-methylene-20(21)-dehydro-19,24,25,26,27,-pentanor-vitamin d analogs
01/24/2013US20130023681 Stabilized doxercalciferol and process for manufacturing the same
01/17/2013WO2012122451A3 Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
01/03/2013WO2013003307A1 2-methylene-(22e)-25-hexanoyl-24-oxo-26,27-cyclo-22-dehydro-19-nor-vitamin d analogs
01/03/2013US20130006003 New synthones for preparation of 19-nor vitamin d derivatives
01/03/2013US20130005686 2-Methylene-(22E)-25-Hexanoyl-24-OXO-26,27-Cyclo-22-Dehydro-19-Nor-Vitamin D Analogs
01/02/2013CN102850248A Technology for preparing vitamin D3
12/2012
12/20/2012WO2012174095A1 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
12/20/2012US20120322775 3-Desoxy-2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
12/20/2012CA2824870A1 3-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
12/06/2012WO2012166938A2 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309719 (22e)-2-methylene-26,27-cyclo-22-dehydro-1alpha-hydroxy-19-norvitamin d3 derivatives
12/06/2012US20120309713 N-Cyclopropyl-(20R)-2-Methylene-19,26,27-Trinor-25-Aza-Vitamin D Analogs and Their Uses
12/06/2012CA2837882A1 (22e)-2-methylene-26,27-cyclo-22-dehydro-1.alpha.-hydroxy-19-norvitamin d3 derivatives
11/2012
11/29/2012WO2011119610A3 (20S)-2-METHYLENE-19-NOR-22-DIMETHYL-1α,25- DIHYDROXYVITAMIN D3 AND (20R)-2-METHYLENE-19-NOR-22- DIMETHYL-1α,25-HYDROXYVITAMIN D3
11/28/2012CN102796134A Preparation method for Maxacalcitol intermediate
11/28/2012CN101462994B Vitamin D derivatives
11/27/2012CA2531505C (20s)-1.alpha.-hydroxy-2-methylene-19-nor-vitamin d3 and its uses
11/22/2012WO2012158794A1 N-cyclopropyl-(20r)-2-methylene-19,26,27-trinor-25-aza-vitamin d analogs and their uses
11/15/2012US20120289723 Method for preparing indene derivatives, and intermediates for preparation of derivatives
11/14/2012CN102775337A 9, 10-ring-opening steroidal compounds, preparation method and application thereof
11/08/2012WO2012151420A1 2α-METHYL AND 2β-METHYL ANALOGS OF 19,26-DINOR-1α, 25-DIHYDROXYVITAMIN D3 AND THEIR USES
11/08/2012US20120283228 2alpha-Methyl and 2beta-Methyl Analogs of 19,26-Dinor-1alpha,25-Dihydroxyvitamin D3 and Their Uses
11/08/2012US20120283227 (20S)-24-(p-Toluenesulfonyloxy)-25,26,27-Trinorvitamin D3 Analogs and Their Uses
11/01/2012US20120277180 Cofactors and Methods for Use for Individuals
10/2012
10/30/2012CA2510228C 25-so2-substituted analogs of 1.alpha.,25-dihydroxyvitamin d3
10/25/2012US20120270839 Compositions and methods for cancer treatment
10/17/2012EP2509943A1 2-methylene-19,26-nor-(20s)-l&-hydroxyvitamin d3
10/16/2012CA2589229C 9,10-secopregnane derivatives and medicine
10/16/2012CA2588063C 2-methylene-19,21-dinor-1.alpha.-hydroxy-bishomopregnacalciferol
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
09/2012
09/27/2012US20120244627 Methods for Quantifying Vitamin D Metabolites by Mass Spectrometry
09/18/2012CA2588417C 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
09/13/2012WO2012122451A2 Polymorphs of maxacalcitol and process for the preparation of maxacalcitol
09/07/2012WO2012118154A1 Novel vitamin d receptor modulator with partial agonist activity
09/05/2012CN101316813B Method for producing vitamin D derivative by using convergent method
08/2012
08/22/2012EP2237837B1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
08/22/2012CN101695648B Negative pressure continuous ultraviolet photochemical reactor
08/14/2012CA2597624C 2-methylene-19-nor-(20s-24s)-1.alpha.,25-dihydroxyvitamin-d2
08/08/2012EP2483240A2 1-desoxy-2-methylene-19-nor-vitamin d analogs and their uses
08/01/2012CN102617690A Vitamin d derivatives
07/2012
07/19/2012US20120184514 Vitamin d compounds and methods for preparing same
07/18/2012CN101316814B Method for producing vitamin D derivative utilizing photoreaction
07/17/2012US8222236 2-methylene-(20E)-20(22)-dehydro-19-nor-vitamin D analogs
07/11/2012CN102558006A Method for separating vitamin D3 from tachysterol T3
07/10/2012US8217023 19-nor-vitamin D analogs with 1,2- or 3,2-cyclopentene ring
07/10/2012CA2588415C 2-methylene-19,26,27-trinor-(20s)-1-alpha-hydroxyvitamin d3 and its uses
07/10/2012CA2562535C 2-alkylidene-18,19-dinor-vitamin d compounds
07/04/2012CN101400649B Isomerisation of pharmaceutical intermediates
07/04/2012CN101381336B Vitamin D3 preparation method and device
07/03/2012US8212059 Process for producing vitamin D derivative using photoreaction
06/2012
06/28/2012US20120165300 Diastereomers of 2-methylene-19-nor-22-methyl-1alpha,25-dihydroxyvitamin d3
06/21/2012US20120157418 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
06/20/2012EP2021321B1 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin d3 and uses thereof
06/13/2012EP2462113A2 New synthones for preparation of 19-nor vitamin d derivatives
06/13/2012EP2001841B1 2-methylene-1 alpha-hydroxy-18,19,21-trinorvitamin d3 analogs and uses thereof
06/12/2012US8198263 Vitamin D derivatives active on the vitamin D nuclear receptor, preparation and uses thereof
06/12/2012CA2635784C Arginine heteromers for topical administration
06/06/2012EP2001842B1 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
06/05/2012US8193171 13,13-dimethyl-des-C,D analogs of 1α,25-dihydroxy-19-nor-vitamin D3 compounds and topical composition dosage forms and methods of treating skin conditions thereof
06/05/2012US8193170 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
06/05/2012US8193169 (20R)-2α-methyl-19,26,2-trinor-vitamin D analogs
05/2012
05/30/2012CN202238034U Photochemical reaction device for preparing vitaminD3
05/30/2012CN102482210A 维生素d受体激动剂及其用途 Vitamin d receptor agonists and their use
05/18/2012WO2012065050A1 22-haloacetoxy-homopregnacalciferol analogs and their uses
05/10/2012US20120115824 Vitamin D Receptor Agonists and Uses Thereof
05/09/2012EP1613588B1 2-propylidene-19-nor-vitamin d compounds
1 2 3 4 5 6 7 8 9 10 11 12 ... 35